Insuman Rapid

Insulin human, the active ingredient in Insuman Rapid, is a short‑acting insulin presented as a solution for injection for intravenous and subcutaneous use. It treats diabetes mellitus in both type 1 and type 2 patients.

GNH USA supplies Insuman Rapid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Rapid is a rapid‑acting insulin used to control blood glucose in diabetes mellitus. - Type 1 diabetes mellitus: provides prandial glucose control to match meals. - Type 2 diabetes mellitus: used as a mealtime insulin to improve post‑prandial glucose levels. - Pre‑operative hyperglycemia: helps achieve target glucose concentrations before surgery.

Common Side Effects: - Hypoglycemia: low blood glucose levels, especially if meals are missed or dosing is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase due to improved glucose utilization. - Lipodystrophy: localized fat accumulation or loss at injection sites. - Allergic skin reactions: rash or urticaria.

Serious or Rare Side Effects: - Severe hypoglycemia: neurological impairment, seizures, or loss of consciousness. - Anaphylaxis: life‑threatening allergic reaction with airway compromise. - Insulin edema: fluid retention leading to peripheral swelling. - Hypokalemia: low serum potassium, particularly with high insulin doses. - Severe allergic reaction: serum sickness‑like symptoms or angioedema.

Before using Insuman Rapid, consider the following precautions. - Dose adjustment: monitor blood glucose frequently and titrate dose as directed. - Hypoglycemia risk: educate patients on recognizing and treating low glucose. - Renal impairment: may require dose modification due to reduced insulin clearance. - Pregnancy: use only if the potential benefit outweighs the risk to the fetus. - Concomitant beta‑blockers: may mask hypoglycemia symptoms. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Rapid may interact with several medications. Major Interactions (Avoid): - Alcohol: can cause unpredictable glucose fluctuations and potentiate hypoglycemia. - High‑dose glucocorticoids: increase insulin resistance, requiring higher insulin doses. - Thiazide diuretics: may raise blood glucose, reducing insulin effectiveness. Moderate Interactions (Monitor Closely): - Sulfonylureas or other oral hypoglycemics: additive glucose‑lowering effect, increasing hypoglycemia risk. - Beta‑blockers: may blunt adrenergic warning signs of hypoglycemia.